Europe - BIT:SOL - IT0001206769 - Common Stock
The current stock price of SOL.MI is 49 EUR. In the past month the price decreased by -2.32%. In the past year, price increased by 35.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AI.PA | AIR LIQUIDE SA | 27.07 | 98.20B | ||
| AIL.DE | AIR LIQUIDE SA | 26.99 | 97.91B |
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza and currently employs 7,412 full-time employees. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
SOL SPA
Via Borgazzi, 27
Monza MONZA E BRIANZA IT
Employees: 7200
Phone: 3903923961
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza and currently employs 7,412 full-time employees. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
The current stock price of SOL.MI is 49 EUR. The price increased by 1.34% in the last trading session.
SOL SPA (SOL.MI) has a dividend yield of 0.81%. The yearly dividend amount is currently 0.42.
SOL.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for SOL SPA (SOL.MI) is 28.49. This is based on the reported non-GAAP earnings per share of 1.72 and the current share price of 49 EUR.
SOL SPA (SOL.MI) will report earnings on 2026-03-25, after the market close.
ChartMill assigns a technical rating of 4 / 10 to SOL.MI. When comparing the yearly performance of all stocks, SOL.MI is one of the better performing stocks in the market, outperforming 73.55% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to SOL.MI. While SOL.MI has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months SOL.MI reported a non-GAAP Earnings per Share(EPS) of 1.72. The EPS increased by 10.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.17% | ||
| ROA | 6.9% | ||
| ROE | 14.75% | ||
| Debt/Equity | 0.7 |
9 analysts have analysed SOL.MI and the average price target is 54.54 EUR. This implies a price increase of 11.32% is expected in the next year compared to the current price of 49.
For the next year, analysts expect an EPS growth of 9.79% and a revenue growth 10.91% for SOL.MI